Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis
CL Pawlowski, W Li, M Sun, K Ravichandran… - Biomaterials, 2017 - Elsevier
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis
CL Pawlowski, W Li, M Sun, K Ravichandran… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
CL Pawlowski, W Li, M Sun, K Ravichandran… - Biomaterials, 2017 - europepmc.org
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis
CL Pawlowski, W Li, M Sun, K Ravichandran… - Biomaterials, 2017 - infona.pl
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis
CL Pawlowski, W Li, M Sun, K Ravichandran… - 2017 - mds.marshall.edu
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
[HTML][HTML] Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis
CL Pawlowski, W Li, M Sun, K Ravichandran… - Biomaterials, 2017 - ncbi.nlm.nih.gov
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis.
CL Pawlowski, W Li, M Sun, K Ravichandran… - Biomaterials, 2017 - europepmc.org
Intravascular administration of plasminogen activators is a clinically important thrombolytic
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …
strategy to treat occlusive vascular conditions. A major issue with this strategy is the systemic …